arrow_back Back to App

PFAS Accountability: New Rights for Exposed Individuals and Medical Monitoring

This act introduces new rights for individuals exposed to harmful PFAS substances, allowing them to pursue claims in federal court. Citizens can seek coverage for medical examinations to detect PFAS-related diseases, with the responsibility for these costs falling on manufacturers. This aims to encourage companies to prioritize chemical safety.
Key points
Individuals exposed to PFAS can sue manufacturers in federal courts for damages.
The act allows for funding of medical examinations (medical monitoring) to detect PFAS-related diseases early.
Companies responsible for PFAS production or use may bear the costs of medical monitoring, encouraging research into the safety of these substances.
The act does not limit the ability to pursue claims under state law.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7194
Sponsor: Rep. Dean, Madeleine [D-PA-4]
Process start date: 2024-02-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

PFAS Accountability Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7194.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-01.

What are the main provisions?

Key points include:

  • Individuals exposed to PFAS can sue manufacturers in federal courts for damages.
  • The act allows for funding of medical examinations (medical monitoring) to detect PFAS-related diseases early.
  • Companies responsible for PFAS production or use may bear the costs of medical monitoring, encouraging research into the safety of these substances.
  • The act does not limit the ability to pursue claims under state law.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dean, Madeleine [D-PA-4].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Courts and Law Environment